Assessment of late cardiomyopathy by magnetic resonance imaging in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and idarubicin.

about

Assessment of late cardiomyopathy by magnetic resonance imaging in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and idarubicin.

Item

http://www.wikidata.org/entity/Q38815519

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Assessment of late cardiomyopa ...... retinoic acid and idarubicin.

@en

type

Item

label

Assessment of late cardiomyopa ...... retinoic acid and idarubicin.

@en

prefLabel

Assessment of late cardiomyopa ...... retinoic acid and idarubicin.

@en

P1476

Assessment of late cardiomyopa ...... s retinoic acid and idarubicin

@en

P2093

Alicia Maceira-González

http://www.w3.org/2001/XMLSchema#string

Antonio Salvador

http://www.w3.org/2001/XMLSchema#string

Begoña Igual

http://www.w3.org/2001/XMLSchema#string

Blanca Boluda

http://www.w3.org/2001/XMLSchema#string

Carlos Carretero

http://www.w3.org/2001/XMLSchema#string

David Martínez-Cuadrón

http://www.w3.org/2001/XMLSchema#string

Guillermo Sanz

http://www.w3.org/2001/XMLSchema#string

Jaime Sanz

http://www.w3.org/2001/XMLSchema#string

Jordi Estornell

http://www.w3.org/2001/XMLSchema#string

José María Fernández

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of doxorubicin-induced cardiomyopathy by reduced glutathione

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging.

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.

Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group.

Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance.

Pretreatment and routine echocardiogram monitoring during chemotherapy for anthracycline-induced cardiotoxicity rarely identifies significant cardiac dysfunction or alters treatment decisions: a 5-year review at a single pediatric oncology center.

The prominent role of cardiac magnetic resonance imaging in coronary artery disease.

Cardiac toxicity 4 to 20 years after completing anthracycline therapy.

Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia.

P304

1077-1084

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00277-017-3004-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mar Tormo

Spanish Group on Myelodysplastic Syndromes (GES MD)

P577

2017-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28451804

http://www.w3.org/2001/XMLSchema#string

P921

leukemia